CHICAGO & SHANGHAI--(BUSINESS WIRE)--JS InnoPharm Ltd initiated the JSI-1187 plus dabrafenib combination dose-escalation phase of the Phase 1 study for patients with locally advanced or metastatic ...
SEATTLE--(BUSINESS WIRE)--NodeSource, the leader in Node.js observability, application management, monitoring, and security, today announced the open sourcing and release of its N|Solid Runtime. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results